N'Kapharma Pharmaceutical Export Pty Ltd

Regulatory action due to The certification under paragraph 26A(2)(j) of the Act, is incorrect (paragraph 30(2)(ba) of the Act) The presentation of the goods in the case of listed goods is unacceptable (paragraph 30(2)(aa) of the Act) The goods have changed so that they have become separate and distinct from the goods in the ARTG (paragraph 30(2)(b) of the Act) The goods do not conform to a standard applicable to the goods (paragraph 30(2)(e) of the Act) The goods do not comply with an applicable provision of the Therapeutic Goods Advertising Code, and/or any other requirement relating to advertising applicable under Part 5-1 or the regulations (paragraph 30(2)(ea) of the Act), effective 22/09/2017